School of Medicine
Showing 81-92 of 92 Results
Director, Stanford Cancer Institute, Jerome and Daisy Low Gilbert Professor and Professor of Biochemistry
Current Research and Scholarly Interests Telomeres are nucleoprotein complexes that protect chromosome ends and shorten with cell division and aging. We are interested in how telomere shortening influences cancer, stem cell function, aging and human disease. Telomerase is a reverse transcriptase that synthesizes telomere repeats and is expressed in stem cells and in cancer. We have found that telomerase also regulates stem cells and we are pursuing the function of telomerase through diverse genetic and biochemical approaches.
Professor of Medicine (Primary Care and Population Health)
Current Research and Scholarly Interests Describe your current research interest and activities
Euan A. Ashley
Associate Dean, School of Medicine, Professor of Medicine (Cardiovascular), of Genetics, of Biomedical Data Science and, by courtesy, of Pathology at the Stanford University Medical Center
Current Research and Scholarly Interests The Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve the diagnosis of genetic disease and to personalize the practice of medicine. At the wet bench, we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality in biological pathways and find targets for therapeutic development.
Associate Professor of Medicine (Primary Care and Population Health) and of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center
Bio Dr. Rebecca A. Aslakson is an Associate Professor at Stanford University with appointments in both the Department of Primary Care & Population Health in the Palliative Care Section and the Department of Anesthesiology, Perioperative and Pain Medicine where she serves as Division Chief of Critical Care Anesthesia. With a Summa Cum Laude B.A. from Washington University in St. Louis, an MD from Harvard Medical School–MIT, and an MSci degree with Distinction from the University of Ulster in Northern Ireland, Dr. Aslakson completed anesthesia residency at Massachusetts General Hospital and surgical critical care fellowship at The Johns Hopkins Hospital, where she was on faculty from 2008-2017. In 2013, Dr. Aslakson obtained her PhD in Clinical Investigations from The Johns Hopkins Bloomberg School of Public Health with her dissertation concerning integration of palliative care in intensive care units. Triple boarded in anesthesia, surgical critical care, and palliative medicine, Dr. Aslakson is an active researcher and clinician; her goal is to improve delivery of effective and equitable palliative care, particularly to perioperative and critically ill populations. She has published over 80 peer-reviewed papers, invited editorials, and book chapters and received competitive funding from funders such as AHRQ, PCORI, the Foundation for Anesthesia Education and Research, and the National Palliative Care Research Society. Dr. Aslakson serves on national committees for professional societies including the American Academy of Hospice and Palliative Medicine (AAHPM), the American Society of Anesthesiologists (ASA), and the Society of Critical Care Medicine (SCCM). Dr. Aslakson has received national awards including the 2015 AAHPM Early Career Investigator Award and the 2014 ASA Presidential Scholar Award. Dr. Aslakson clinically attends at the Stanford University Medical Center in the M4 and E2 Intensive Care Units and on the inpatient palliative care clinical service. She lives in Palo Alto, CA with her husband and two sons.
Themistocles (Tim) Assimes
Associate Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Health Research and Policy (Epidemiology)
Current Research and Scholarly Interests Genetic Epidemiology, Genetic Determinants of Complex Traits related to Cardiovasular Medicine, Coronary Artery Disease related pathway analyses and integrative genomics, Mendelian randomization studies, risk prediction for major adverse cardiovascular events, cardiovascular medicine related pharmacogenomics, ethnic differences in the determinants of Insulin Mediated Glucose Uptake, pharmacoepidemiology of cardiovascular drugs & outcomes
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
Bio Dr. Ayati completed his residency at UC Davis and his fellowship at Stanford University. During his residency at UC Davis, Dr. Ayati received the Award of Excellence in Clinical Teaching. Dr. Ayati worked at hospitals such as Lodi Memorial Hospital in Lodi, California, and as an Emergency Medicine Attending at Veteran Affairs in Palo Alto, California. Dr. Ayati worked as a Stanford Medical Director at Los Altos and Palo Alto Sub acute and Rehabilitation centers. Dr. Ayati has a broad spectrum of practice and knowledge of general medicine and primary care in various settings, from office to Emergency room and acute and Sub-acute cares. Dr. Ayati’s main areas of research and clinical focus are in the physiology of aging and on finding practical and yet innovative ways of addressing the wellbeing and needs of the population in any age category. Dr. Ayati is an advocate of his patient’s physical and mental health at any age in addition to disease management and prevention. Dr. Ayati is currently the Editor in Chief of the journal of General Medicine, Open Access. Dr. Ayati is the author of “Paths to Healthy Aging”. Dr. Ayati is also a guest educational speaker on several radio stations such as National Public Radio (NPR) and San Francisco’s KQED and international and national conferences.
Dr. Ayati strives to provide reliable information, effective strategies, and simple guidelines for patients of all ages to avoid or manage chronic diseases and to have a significantly better quality of life.
Adjunct Professor, Medicine
Bio Farzad Azimpour is a health technology designer and cardiologist serving as Chief Medical Officer at Myia Health, Adjunct Professor (Medicine) at Stanford University School of Medicine, and Assistant Director (Design) at Stanford Byers Center for Biodesign.
In partnership with the American College of Cardiology, Dr. Azimpour leads clinical design implementation at Myia Health, a digital health platform service for contextualized patient data monitoring, analytics, and clinical decision-making.
Academically, he leads creative design strategy at Stanford Biodesign. He co-directed the inaugural Stanford Medicine course titled MED267 on design for the human experience in medicine with Dr. Abraham Verghese and colleagues. He is also a contributor to the Stanford Presence 5 research team, designing the future of human clinical interactions in an increasingly digital ecosystem.
Prior to his current roles, Dr. Azimpour served as Director of Health at the global design and innovation firm IDEO. He was the 2014 St. Jude Medical and Dean's Innovation Fellow at Stanford Biodesign after completing his clinical training in internal medicine and cardiology at Cleveland Clinic and the University of Minnesota's Lillehei Heart Institute, respectively. He served as Chief Cardiology Fellow and was awarded an NIH T32 fellowship in advanced cardiovascular technologies where he led feasibility studies on acoustic detection of coronary artery stenosis, augmented vascular access, and implantable cardio-embolic stroke protection systems.
Dr. Azimpour holds a Bachelor's degree in Biological Sciences from The University of Texas at Austin, an MD from The University of Texas Medical Branch, and a post-doctoral designation in Biodesign from Stanford University School of Medicine.
He is a recipient of Phi Beta Kappa distinction and the Arnold P. Gold Foundation Humanism in Medicine Award.